Clinical Trial Update: Freedom Study: Myfortic in Kidney Transplant Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Myfortic (mycophenolate mofetil) in kidney transplant patients shows the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED